Anti-coagulation factor XI antibodies
US12275800B2 · kind B2 · utility
0Cited by
40References
18Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Apr 18, 2023 |
| Grant date | Apr 15, 2025 |
| Priority date | — |
| Expiry date | Jul 7, 2043 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/92
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Antibodies that bind the apple 3 domain of human coagulation Factor XI and inhibit activation of FXI by coagulation factor XIIa as well as activation of FIX by FXIa are described.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.